Pacer Advisors
TAK icon

Pacer Advisors’s Takeda Pharmaceutical TAK Stock Holding History

Pacer Advisors’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-27,999
Closed -$416K – 3590
2025
Q1 		$416K Buy
27,999
+807
+3% +$11.3K ﹤0.01% 1539
2024
Q4 		$360K Buy
27,192
+135
+0.5% +$1.85K ﹤0.01% 1717
2024
Q3 		$385K Sell
27,057
-865
-3% -$12.3K ﹤0.01% 1713
2024
Q2 		$361K Sell
27,922
-560
-2% -$7.41K ﹤0.01% 1680
2024
Q1 		$396K Sell
28,482
-284
-1% -$4.13K ﹤0.01% 1629
2023
Q4 		$410K Sell
28,766
-897,979
-97% -$12.7M ﹤0.01% 1602
2023
Q3 		$14.3M Buy
926,745
+29,211
+3% +$452K 0.05% 276
2023
Q2 		$14.1M Sell
897,534
-679,335
-43% -$11.1M 0.06% 295
2023
Q1 		$26M Buy
1,576,869
+550,572
+54% +$8.77M 0.11% 186
2022
Q4 		$16M Sell
1,026,297
-61,285
-6% -$856K 0.08% 196
2022
Q3 		$14.1M Buy
1,087,582
+241,326
+29% +$3.36M 0.1% 159
2022
Q2 		$11.9M Buy
846,256
+419,798
+98% +$5.99M 0.09% 197
2022
Q1 		$6.11M Buy
426,458
+160,896
+61% +$2.36M 0.05% 379
2021
Q4 		$3.62M Buy
265,562
+109,095
+70% +$1.53M 0.04% 585
2021
Q3 		$2.56M Sell
156,467
-1,823
-1% -$30.6K 0.03% 617
2021
Q2 		$2.66M Buy
158,290
+26,164
+20% +$445K 0.04% 529
2021
Q1 		$2.41M Sell
132,126
-7,185
-5% -$129K 0.04% 456
2020
Q4 		$2.54M Buy
139,311
+107,435
+337% +$1.89M 0.05% 384
2020
Q3 		$569K Buy
+31,876
New +$580K 0.01% 950
2020
Q1 		– Sell
-24,123
Closed -$476K – 1067
2019
Q4 		$476K Buy
24,123
+7,100
+42% +$136K 0.02% 796
2019
Q3 		$293K Buy
17,023
+6,091
+56% +$105K 0.01% 1071
2019
Q2 		$193K Sell
10,932
-82,373
-88% -$1.5M ﹤0.01% 1058
2019
Q1 		$1.9M Sell
93,305
-1,887
-2% -$38K 0.05% 307
2018
Q4 		$1.6M Buy
+95,192
New +$1.61M 0.06% 64

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Pacer Advisors's TAK Position: Q2 2025 in Review

Pacer Advisors sold out of Takeda Pharmaceutical (TAK) in Q2 2025, closing a stake of 27,999 shares — an estimated $416K sold.

Pacer Advisors first reported a position in TAK in Q4 2018 and held it in 24 quarters. The position peaked at $26M in Q1 2023. 315 funds tracked by Wall St. Rank hold TAK as of Q2 2025.

  • Pacer Advisors reported no remaining Takeda Pharmaceutical position as of Q2 2025 after selling out during the quarter.
  • Pacer Advisors sold 27,999 Takeda Pharmaceutical shares in Q2 2025, an estimated $416K.
  • Pacer Advisors first reported a position in Takeda Pharmaceutical in Q4 2018 and held it in 24 quarters.
  • Pacer Advisors's Takeda Pharmaceutical position peaked at $26M in Q1 2023.
  • 315 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2025.

Based on Pacer Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.